FDA Inspection
VitalantVitalant – FDA Inspection, Jun 27, 2010
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on June 27, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- June 27, 2010
- Product Type
- Biologics
View Company Profile
ID · ac71aa7a-6688-4aeb-ab20-a0c1912aae95
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 670230
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.60(b)Equipment calibration frequency
- 21 CFR 606.171Biological product deviation report
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 30, 2025 | Not classified | Los Angeles District Office | |
| February 24, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| July 12, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 19, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 15, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1269240 - 2025-04-30
- FDA Inspection 1163403 - 2022-02-24
- FDA Inspection 1059991 - 2018-07-12
- FDA Inspection 960998 - 2016-02-19
- FDA Inspection 897348 - 2014-09-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.